Solubility prediction of salmeterol xinafoate in water--dioxane mixtures. 2001

A Jouyban-Gharamaleki, and P York, and M Hanna, and B J Clark
Drug Design Group, School of Pharmacy, University of Bradford, Bradford BD7 1DP, UK. ghasem@pharm.usyd.edu.au

The mole fraction solubility of salmeterol xinafoate was determined in various concentrations of dioxane in aqueous binary mixture. Maximum solubility was observed in 90% v/v dioxane and solubility parameter of the solute was estimated from solubility peak equal to 24.99 MPa(0.5). The predicting capability of four different cosolvency models was also evaluated employing a five data point training set. The solubility data at other cosolvent concentrations were predicted using the trained models, with percentage average errors for 28 drug solubility data sets in water-cosolvent mixtures lying between 12.5 and 15.0%. Further predictive model is proposed for accurate solubility predictions based on a minimum number of experiments. The percentage average error where tested was 10.6%.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D004146 Dioxanes Compounds that contain the structure 1,4-dioxane.
D000068299 Salmeterol Xinafoate A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Salmeterol,Serevent,Xinafoate, Salmeterol
D000420 Albuterol A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. Salbutamol,2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol,Albuterol Sulfate,Proventil,Sultanol,Ventolin
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D012997 Solvents Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant & Hackh's Chemical Dictionary, 5th ed) Solvent
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide

Related Publications

A Jouyban-Gharamaleki, and P York, and M Hanna, and B J Clark
February 1969, Journal of pharmaceutical sciences,
A Jouyban-Gharamaleki, and P York, and M Hanna, and B J Clark
June 1965, Journal of pharmaceutical sciences,
A Jouyban-Gharamaleki, and P York, and M Hanna, and B J Clark
January 2007, Die Pharmazie,
A Jouyban-Gharamaleki, and P York, and M Hanna, and B J Clark
June 1980, Journal of pharmaceutical sciences,
A Jouyban-Gharamaleki, and P York, and M Hanna, and B J Clark
January 2015, Profiles of drug substances, excipients, and related methodology,
A Jouyban-Gharamaleki, and P York, and M Hanna, and B J Clark
May 2011, Indian journal of pharmaceutical sciences,
A Jouyban-Gharamaleki, and P York, and M Hanna, and B J Clark
April 1995, The Medical journal of Australia,
A Jouyban-Gharamaleki, and P York, and M Hanna, and B J Clark
January 1994, JAMA,
A Jouyban-Gharamaleki, and P York, and M Hanna, and B J Clark
June 1983, Journal of pharmaceutical sciences,
A Jouyban-Gharamaleki, and P York, and M Hanna, and B J Clark
November 2006, Pharmaceutical research,
Copied contents to your clipboard!